Sedia Biosciences Corp. Email Format
Biotechnology ResearchOregon, United States11-50 Employees
Sedia Biosciences Corp. is a privately held biotechnology company focused on medical devices and diagnostics, based in Beaverton, Oregon. Founded in 2009, it develops and licenses technologies and products aimed at expanding global access to care, including rapid tests designed for point-of-care use and assays that accommodate non-traditional specimens such as oral fluid or urine. The company also pursues epidemiological tools, notably HIV incidence testing, and creates novel specimen collection devices intended to support remote sampling for follow-up testing. With a multidisciplinary team of researchers, scientists, and business professionals, Sedia develops, manufactures, and licenses these technologies and products for international deployment. In 2026, Sedia expanded its distribution reach through a co-exclusive agreement with Thermo Fisher Scientific to offer certain genomics products worldwide. These developments accompany the company’s ongoing focus on public health and diagnostic science, and reflect its role within the biotechnology research sector.